Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

SHE:300119 Revenue

Tianjin Ringpu Bio-Technology had revenue of 826.13M CNY in the quarter ending March 31, 2026, with 0.55% growth. This brings the company's revenue in the last twelve months to 3.40B, up 6.11% year-over-year. In the year 2025, Tianjin Ringpu Bio-Technology had annual revenue of 3.40B with 10.70% growth.

• Revenue (ttm): 3.40B
• Revenue Growth: +6.11%
• P/S Ratio: 2.29
• Revenue / Employee: 1.21M
• Employees: 2,803
• Market Cap: 7.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.40B	328.53M	10.70%
Dec 31, 2024	3.07B	360.83M	13.32%
Dec 31, 2023	2.71B	624.85M	29.98%
Jan 1, 2023	2.08B	77.11M	3.84%
Jan 1, 2022	2.01B	6.73M	0.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error